Chilcott, Jim

Jim Chilcott

BSc (Manchester), MSc (Strathclyde)

School of Medicine and Population Health

Professor of Healthcare Decision Modelling

j.b.chilcott@sheffield.ac.uk
+44 114 222 0689

+44 114 222 0749 (Fax)

Regent Court (ScHARR)

Full contact details

Jim Chilcott
School of Medicine and Population Health
Regent Court (ScHARR)
30 Regent Street
��«Ӱҵ
S1 4DA

Profile

I gained my Mathematics degree from the University of Manchester in 1985 and my MSc in Operational Research from Strathclyde in 1986. For 10 years following the MSc I worked in Operational Research consultancy, giving practical decision support right across the health sector from hospitals to department, in addition to the mining, banking and education sectors.

I joined ScHARR in 1996 to focus on healthcare decision support. From 2002 to 2008 I was the Technical Director of ScHARR Technology Assessment Group responsible for the scientific quality of the group's work for the NICE Technology Appraisals Programme.

I am a founding member and Technical Director of the Public Health Collaborating Centre at ScHARR.

Research interests

Modelling in public health
Modelling in cancer and cancer screening
Methodological modelling interests including:
- the modelling process and errors in HTA models
- cognitive mapping for systematic reviews in complex settings
- structural uncertainty in models
- Bayesian analysis of joint disease natural history and test characteristics in screening
- value of information methods
- probabilistic sensitivity analysis methods
- meta-modelling
- information gathering processes for models

Current projects

National Institute for Health and Clinical Excellence (NICE) (2011-2012): NICE Collaborating Centre for Public Health Excellence. With E Goyder, S Paisley, R L Akehurst
NHS Cancer Screening Programmes (2010-2011): Revisiting the options appraisal for colorectal cancer screening. With S Whyte
UK National Screening Committee (2009-2010): Prostate Cancer Screening Options Appraisal Parts I & II. With S Hummel
NHS Cancer Screening Programmes (2009-2010): Bowel cancer screening in England: Analysis of the FOBT referral point. With S Whyte
National Cancer Registry of Ireland (2009-2011): Cost-effectiveness of strategies for colorectal cancer prevention in Ireland. With S Whyte and H Pilgrim
National Institute for Health and Clinical Excellence (NICE) (2008-2011): NICE Collaborating Centre for Public Health Excellence. With E Goyder, S Paisley and R Akehurst
NHS Cancer Screening Programme (2008-2013): Analytical support to the Bowel Cancer Screening Programme.

Publications

Show: Featured publications All publications

Featured publications

Journal articles

Kearns B, Chilcott J, Whyte S, Preston L & Sadler S (2016) . BMC Medicine, 14(1), 200-200.
Breeze P, Squires H, Chilcott J, Stride C, Diggle PJ, Brunner E, Tabak A & Brennan A (2016) . J Public Health (Oxf), 38(4), 679-687.
McNamee P, Murray E, Kelly MP, Bojke L, Chilcott J, Fischer A, West R & Yardley L (2016) . American Journal of Preventive Medicine, 51(5), 852-860.
Squires H, Chilcott J, Akehurst R, Burr J & Kelly MP (2016) . Value in Health, 19(5), 588-601.
Squires H, Chilcott J, Akehurst R, Burr J & Kelly MP (2016) . International Journal of Public Health, 61(3), 289-298.
Tappenden P & Chilcott J (2014) . Value in Health, 17(7), A585-A585.
Kearns B, Whyte S, Chilcott J & Patnick J (2014) . British Journal of Cancer, 111(9), 1734-1741.
Tappenden P & Chilcott JB (2014) . Pharmacoeconomics, 32(10), 967-979.
Rawdin AC, Duenas A & Chilcott JB (2014) . Public Health, 128(9), 804-810.
Tappenden P, Chilcott J, Brennan A, Squires H, Glynne-Jones R & Tappenden J (2013) . Value in Health.

All publications

Journal articles

Chang JYA, Rex SS, Chilcott JB & Latimer NR (2024) . Value in Health, 27(12), S450-S450.
Mandrik O, Thomas C & Chilcott J (2024) Development of the Microsimulation Model in Cancers of Bladder and Kidney (MiMiC-BlaKy). HEDS Discussion Paper Series(24.03).
Kar D, El-Wazir A, Nath M, Breeze P, Jetha K, Strong M, Chilcott J, Davies MJ, Lee A, Lusignan SD , Khunti K et al (2023) . BMJ Public Health, 1(1).
Hock ES, Franklin M, Baxter S, Clowes M, Chilcott J & Gillespie D (2023) . NIHR Open Research, 3(28).
Catto JWF, North B, Goff M, Carter A, Sleeth M, Mandrik O, Chilcott J, Sasieni P & Cumberbatch MGK (2023) . BMJ Open, 13(9), e076612-e076612.
Mandrik O, Hahn AI, Catto JWF, Zauber AG, Cumberbatch M & Chilcott J (2023) . PharmacoEconomics.
Catto JWF, Mandrik O, Quayle LA, Hussain SA, McGrath J, Cresswell J, Birtle AJ, Jones RJ, Mariappan P, Makaroff LE , Knight A et al (2023) . BJU International.
Mahdi S, Chilcott J & Buckland NJ (2022) . Lancet, 400 Suppl 1, S13.
Mahdi S, Chilcott J & Buckland NJ (2022) . The Lancet, 400, S13-S13.
Mandrik O, Chilcott J & Thomas C (2022) . Preventive Medicine, 160.
Mandrik O, Thomas C, Whyte S & Chilcott J (2022) . PharmacoEconomics.
Mahdi S, Marr C, Buckland NJ & Chilcott J (2022) . Obesity Reviews.
Tong T, Aber A, Chilcott J, Thokala P, Walters SJ, Maheswaran R, Nawaz S, Thomas S & Michaels J (2021) . British Journal of Surgery, 108(5), 521-527.
Whyte S, Thomas C, Chilcott J & Kearns B (2021) . Value in Health.
Romero CP, Marinho DS, Castro R, de Aguiar Pereira CC, Silva E, Caetano R, Silva Elias FT, Chilcott J & Dixon S (2020) . Value in Health Regional Issues, 23, 61-69.
Bessey A, Chilcott J, Pandor A & Paisley S (2020) . International Journal of Neonatal Screening, 6(4).
Moat SJ, Dibden C, Tetlow L, Griffith C, Chilcott J, George R, Hamilton L, Wu THY, MacKenzie F & Hall SK (2020) . Bioanalysis, 12(2), 99-109.
Aber A, Tong T, Chilcott J, Maheswaran R, Thomas SM, Nawaz S & Michaels J (2019) . BMC Health Services Research, 19(1).
Bessey A, Chilcott J, Leaviss J, de la Cruz C & Wong R (2019) . International Journal of Neonatal Screening, 5(3).
Thomas C, Whyte S, Kearns B & Chilcott JB (2019) . Value in Health, 22(10), 1154-1161.
Aber A, Tong T, Chilcott J, Maheswaran R, Thomas SM, Nawaz S & Michaels J (2018) . European Journal of Vascular and Endovascular Surgery, 56(6), e30-e30.
Aber A, Tong TS, Chilcott J, Thokala P, Maheswaran R, Thomas SM, Nawaz S, Walters S & Michaels J (2018) . British Journal of Surgery.
Bessey A, Chilcott JB, Leaviss J & Sutton A (2018) . Orphanet J Rare Dis, 13(1), 179-179.
Kearns B, Chilcott J, Relton C, Whyte S, Woods HB, Nickerson C & Loban A (2018) . Cancer Management and Research, 10, 637-645.
Burns J, Polus S, Brereton L, Chilcott J, Ward SE, Pfadenhauer LM & Rehfuess EA (2017) . Research Synthesis Methods.
Brereton L, Wahlster P, Mozygemba K, Lysdahl K, Burns J, Polus S, Tummers M, Refolo P, Sacchini D, Leppert W , Chilcott J et al (2017) . International Journal of Technology Assessment in Health Care, 33(5), 552-561.
Sadler S, Tosh J, Pennington R, Rawdin A, Squires H, Romero C, Fischer A & Chilcott J (2017) . Journal of Epidemiology and Community Health, 71, 897-904.
Lysdahl KB, Mozygemba K, Burns J, Brönneke JB, Chilcott JB, Ward S & Hofmann B (2017) . International Journal of Technology Assessment in Health Care, 33(5), 570-576.
Breeze PR, Thomas C, Squires H, Brennan A, Greaves C, Diggle P, Brunner E, Tabak A, Preston L & Chilcott J (2017) . Diabetic Medicine, 34(8), 1136-1144.
Breeze PR, Thomas C, Squires H, Brennan A, Greaves C, Diggle PJ, Brunner E, Tabak A, Preston L & Chilcott J (2017) . Diabetic Medicine, 34(5), 632-640.
Brereton L, Ingleton C, Gardiner C, Goyder E, Mozygemba K, Lysdahl KB, Tummers M, Sacchini D, Leppert W, Blazeviciene A , van der Wilt GJ et al (2017) . Palliative Medicine, 31(2), 181-192.
Kearns B, Chilcott J, Whyte S, Preston L & Sadler S (2016) . BMC Medicine, 14(1), 200-200.
Breeze P, Squires H, Chilcott J, Stride C, Diggle PJ, Brunner E, Tabak A & Brennan A (2016) . J Public Health (Oxf), 38(4), 679-687.
McNamee P, Murray E, Kelly MP, Bojke L, Chilcott J, Fischer A, West R & Yardley L (2016) . American Journal of Preventive Medicine, 51(5), 852-860.
Squires H, Chilcott J, Akehurst R, Burr J & Kelly MP (2016) . Value in Health, 19(5), 588-601.
Squires H, Chilcott J, Akehurst R, Burr J & Kelly MP (2016) . International Journal of Public Health, 61(3), 289-298.
Kearns B, Whyte S, Seaman HE, Snowball J, Halloran SP, Butler P, Patnick J, Nickerson C & Chilcott J (2016) . British Journal of Cancer, 114(3), 327-333.
(2016) . Diabetic Medicine, 33(8), 1155-1163.
Tappenden P & Chilcott J (2014) . Value in Health, 17(7), A585-A585.
Kearns B, Whyte S, Chilcott J & Patnick J (2014) . British Journal of Cancer, 111(9), 1734-1741.
Tappenden P & Chilcott JB (2014) . Pharmacoeconomics, 32(10), 967-979.
Watson P, Preston L, Squires H, Chilcott J & Brennan A (2014) . Appl Health Econ Health Policy, 12(3), 239-253.
Rawdin AC, Duenas A & Chilcott JB (2014) . Public Health, 128(9), 804-810.
Everson-Hock ES, Johnson M, Jones R, Woods HB, Goyder E, Payne N & Chilcott J (2013) . Preventive Medicine, 56(5), 265-272.
Sharp L, Tilson L, Whyte S, Ceilleachair AO, Walsh C, Usher C, Tappenden P, Chilcott J, Staines A, Barry M & Comber H (2013) . BMC Health Serv Res, 13, 105.
Tappenden P, Chilcott J, Brennan A, Squires H, Glynne-Jones R & Tappenden J (2013) . Value in Health.
Pollock RF, Chilcott J, Muduma G & Valentine WJ (2013) . J Med Econ, 16(2), 249-259.
Tappenden P, Chilcott J, Brennan A, Squires H & Stevenson M (2012) . Value Health, 15(8), 1127-1136.
Squires H, Chilcott J, Akehurst R & Burr J (2012) . The Lancet, 380, S68-S68.
Whyte S, Chilcott J & Halloran S (2012) . Colorectal Dis, 14(9), e547-e561.
Sharp L, Tilson L, Whyte S, O'Ceilleachair A, Walsh C, Usher C, Tappenden P, Chilcott J, Staines A, Barry M & Comber H (2012) . Br J Cancer, 106(5), 805-816.
Everson-Hock ES, Jones R, Guillaume L, Clapton J, Goyder E, Chilcott J, Payne N, Duenas A, Sheppard LM & Swann C (2012) . Child: Care, Health and Development, 38(2), 162-174.
Tilson L, Sharp L, Usher C, Walsh C, Whyte S, O'Ceilleachair A, Stuart C, Mehigan B, Kennedy MJ, Tappenden P , Chilcott J et al (2012) . European Journal of Health Economics, 13(4), 511-524.
Everson-Hock ES, Jones R, Guillaume L, Clapton J, Duenas A, Goyder E, Chilcott J, Cooke J, Payne N, Sheppard LM & Swann C (2011) . Child Care Health Dev, 37(6), 767-779.
Strong M, Oakley JE & Chilcott J (2011) Managing structural uncertainty in health economic decision models: A discrepancy approach. Journal of the Royal Statistical Society. Series C: Applied Statistics.
Jones R, Everson-Hock ES, Papaioannou D, Guillaume L, Goyder E, Chilcott J, Cooke J, Payne N, Duenas A, Sheppard LM & Swann C (2011) . Child Care Health Dev, 37(5), 613-622.
Whyte S, Walsh C & Chilcott J (2011) . Medical Decision Making, 31(4), 625-641.
Bending MW, Trueman P, Lowson KV, Pilgrim H, Tappenden P, Chilcott J & Tappenden J (2010) . Int J Technol Assess Health Care, 26(4), 362-369.
Chilcott J, Tappenden P, Rawdin A, Johnson M, Kaltenthaler E, Paisley S, Papaioannou D & Shippam A (2010) . Health Technol Assess, 14(25), iii-107.
Oakley JE, Brennan A, Tappenden P & Chilcott J (2010) . J Health Econ, 29(3), 468-477.
Blank L, Baxter S, Naylor PB, Guillaume L, Wilkinson A, Hummel S, Chilcott J & Goyder E (2010) . Mental Health Review Journal, 2(15), 43-53.
Bending MW, Trueman P, Lowson KV, Pilgrim H, Tappenden P, Chilcott J & Tappenden J (2010) . International Journal of Technology Assessment in Health Care, 26(4), 362-369.
McCabe C, Chilcott J, Claxton K, Tappenden P, Cooper C, Roberts J, Cooper N & Abrams K (2010) . BMJ, 340, c1786.
Pilgrim H, Tappenden P, Chilcott J, Bending M, Trueman P, Shorthouse A & Tappenden J (2009) . J OPER RES SOC, 60(10), 1305-1314.
Sharp L, Tilson L, Whyte S, O'Ceilleachair A, Walsh C, Usher C, Tappenden P, Chilcott J, Staines A, Comber H & Barry M (2009) COST-EFFECTIVENESS OF A POPULATION-BASED COLORECTAL CANCER SCREENING PROGRAMME IN IRELAND. VALUE HEALTH, 12(7), A280-A280.
Tappenden P, Chilcott J, Brennan A & Pilgrim H (2009) . Int J Technol Assess Health Care, 25(4), 470-478.
Whyte S, Walsh C, Sharp L, O'Ceilleachair A, Tilson L, Usher C, Chilcott J, Tappenden P, Staines A, Comber H & Barry M (2009) . Value in Health, 12(7), A395-A395.
Chilcott J, Lloyd Jones M & Wilkinson A (2009) . Health Technol Assess, 13 Suppl 1, 7-13.
Pandor A, Ara RM, Tumur I, Wilkinson AJ, Paisley S, Duenas A, Durrington PN & Chilcott J (2009) . J Intern Med, 265(5), 568-580.
Simpson EL, Duenas A, Holmes MW, Papaioannou D & Chilcott J (2009) . Health Technol Assess, 13(17), iii-154.
Tappenden P, McCabe C, Chilcott J, Simpson E, Nixon R, Madan J, Fisk JD & Brown M (2009) . Value Health, 12(5), 657-665.
Kerner JF, Cazap E, Yach D, Pierotti MA, Daidone MG, De Blasio P, Geary P, Schacter B, Sant M, Habbema JDF , Sankaranarayanan R et al (2009) . Tumori, 95(5), 610-622.
Pickin M, Cooper CL, Chater T, O'Hagan A, Abrams KR, Cooper NJ, Boggild M, Palace J, Ebers G, Chilcott JB , Tappenden P et al (2009) . BMC Neurol, 9, 1.
Wailoo A, Bansback N & Chilcott J (2008) . RHEUMATOLOGY, 47(10), 1590-1590.
Ara R, Pandor A, Tumur I, Paisley S, Duenas A, Williams R, Wilkinson A, Durrington P & Chilcott J (2008) . Clin Ther, 30(8), 1508-1523.
Pilgrim H & Chilcott J (2008) . J OPER RES SOC, 59(7), 902-910.
Dixon S, Faghih Nasiri F, Ledger WL, Lenton EA, Duenas A, Sutcliffe P & Chilcott JB (2008) . BJOG, 115(6), 758-766.
Wailoo A, Bansback N & Chilcott J (2008) . Rheumatology (Oxford), 47(2), 119-120.
Ara R, Tumur I, Pandor A, Duenas A, Williams R, Wilkinson A, Paisley S & Chilcott J (2008) . Health Technol Assess, 12(21), iii-212.
Ara R, Pandor A, Tumur I, Paisley S, Duenas A, Williams R, Rees A, Wilkinson A, Durrington P & Chilcott J (2008) . Am J Cardiovasc Drugs, 8(6), 419-427.
Garthwaite PH, Chilcott JB, Jenkinson DJ & Tappenden P (2008) . Int J Technol Assess Health Care, 24(3), 350-357.
Brennan A, Kharroubi S, O'hagan A & Chilcott J (2007) . Med Decis Making, 27(4), 448-470.
Tappenden P, Chilcott J, Eggington S, Patnick J, Sakai H & Karnon J (2007) . Gut, 56(5), 677-684.
Chilcott J (2007) Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis (vol 326, pg 522, 2003). BRIT MED J, 334(7595), 685-685.
Chilcott J (2007) Erratum: Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis (British Medical Journal (2003) 326, (522-525) DOI: 10.1136/bmj.326.7388.522). British Medical Journal, 334(7595), 685.
Tappenden P, Brazier J, Ratcliffe J & Chilcott J (2007) . Pharmacoeconomics, 25(8), 685-693.
Eggington S, Tappenden P, Pandor A, Paisley S, Saunders M, Seymour M, Sutcliffe P & Chilcott J (2006) . Br J Cancer, 95(9), 1195-1201.
Tappenden P, Chilcott J, Ward S, Eggington S, Hind D & Hummel S (2006) . Eur J Cancer, 42(17), 2867-2875.
Mar J, Gutiérrez-Moreno S & Chilcott J (2006) . Gac Sanit, 20(1), 47-53.
Vergel YB, Chilcott J, Kaltenthaler E, Walters S, Blakeborough A & Thomas S (2006) . International Journal of Surgery, 4(1), 12-19.
Pandor A, Eastham J, Chilcott J, Paisley S & Beverley C (2006) . Int J Technol Assess Health Care, 22(3), 321-326.
Kaltenthaler EC, Walters SJ, Chilcott J, Blakeborough A, Vergel YB & Thomas S (2006) . BMC Med Imaging, 6, 9.
Warren E, Weatherley-Jones E, Chilcott J & Beverley C (2004) Systematic review and economic evaluation of a long-acting insulin analogue, insulin glargine. Health technology assessment (Winchester, England), 8(45).
Warren E, Weatherly-Jones E, Chilcott J & Beverley C (2004) Systematic review and economic evaluation of a long-acting insulin analogue, insulin glargine. HEALTH TECHNOL ASSES, 8(45), 1-+.
Warren E, Weatherley-Jones E, Chilcott J & Beverley C (2004) . Health Technol Assess, 8(45), iii-57.
Chilcott J, Tappenden P, Lloyd Jones M, Wight J, Forman K, Wray J & Beverley C (2004) . BJOG, 111(9), 903-907.
Jones ML, Wray J, Wight J, Chilcott J, Forman K, Tappenden P & Beverley C (2004) . BJOG, 111(9), 892-902.
Karnon J, Peters J, Platt J, Chilcott J, McGoogan E & Brewer N (2004) Liquid-based cytology in cervical screening: an updated rapid and systematic review and economic analysis. HEALTH TECHNOL ASSES, 8(20), 1-+.
Karnon J, Peters J, Platt J, Chilcott J, McGoogan E & Brewer N (2004) . Health Technol Assess, 8(20), iii-78.
Holmes M, Chilcott J, Walters S, Whitby S & Akehurst R (2004) . Transpl Int, 17(4), 182-187.
Holmes M, Chilcott J, Walters S, Whitby S & Akehurst R (2004) . Transplant International, 17(4), 182-187.
Czoski-Murray C, Warren E, Chilcott J, Beverley C, Psyllaki MA & Cowan J (2004) . Health Technol Assess, 8(13), iii-91.
Czoski-Murray C, Warren E, Chilcott J, Beverley C, Psyllaki MA & Cowan J (2004) Clinical effectiveness and cost-effectiveness of pioglitazone and rosiglitazone in the treatment of type 2 diabetes: a systematic review and economic evaluation. HEALTH TECHNOL ASSES, 8(13), 1-+.
Kaltenthaler E, Vergel YB, Chilcott J, Thomas S, Blakeborough T, Walters SJ & Bouchier H (2004) . Health Technol Assess, 8(10), iii-89.
Pandor A, Eastham J, Beverley C, Chilcott J & Paisley S (2004) . Health Technol Assess, 8(12), iii-121.
Karnon J, Peters J, Platt J, Chilcott J, McGoogan E & Brewer N (2004) Liquid-based cytology in cervical screening: an updated rapid and systematic review and economic analysis.. Health technology assessment (Winchester, England), 8(20).
Kaltenthaler E, Vergel YB, Chilcott J, Thomas S, Blakeborough T, Walters SJ & Bouchier H (2004) A systematic review and economic evaluation of magnetic resonance cholangiopancreatography compared with diagnostic endoscopic retrograde cholangiopancreatography.. Health technology assessment (Winchester, England), 8(10).
Pandor A, Eastham J, Beverley C, Chilcott J & Paisley S (2004) Clinical effectiveness and cost-effectiveness of neonatal screening for inborn errors of metabolism using tandem mass spectrometry: a systematic review.. Health technology assessment (Winchester, England), 8(12).
Tappenden P, Chilcott JB, Eggington S, Oakley J & McCabe C (2004) Methods for expected value of information analysis in complex health economic models: developments on the health economics of interferon-beta and glatiramer acetate for multiple sclerosis.. Health technology assessment (Winchester, England), 8(27).
Stevenson MD, Oakley J & Chilcott JB (2004) . Med Decis Making, 24(1), 89-100.
Karnon J, Brennan A & Chilcott J (2003) . Eur J Health Econ, 4(3), 239-240.
Wight JP, Chilcott JB, Holmes MW & Brewer N (2003) . Clin Transplant, 17(4), 293-307.
Chilcott J, McCabe C, Tappenden P, O'Hagan A, Cooper NJ, Abrams K, Claxton K, Miller DH & Cost Effectiveness of Multiple Sclerosis Therapies Study Group (2003) . BMJ, 326(7388), 522.
Mar J, Rueda JR, Durán-Cantolla J, Schechter C & Chilcott J (2003) . Eur Respir J, 21(3), 515-522.
Wight J, Chilcott J, Holmes M & Brewer N (2003) The clinical and cost-effectiveness of pulsatile machine perfusion versus cold storage of kidneys for transplantation retrieved from heart-beating and non-heart-beating donors.. Health technology assessment (Winchester, England), 7(25), 1-94.
Wight J, Chilcott J, Holmes M & Brewer N (2003) . Health Technol Assess, 7(25), 1-94.
Chilcott J, Brennan A, Booth A, Karnon J & Tappenden P (2003) The role of modelling in prioritising and planning clinical trials.. Health technology assessment (Winchester, England), 7(23).
Chilcott J, Lloyd Jones M, Wight J, Forman K, Wray J, Beverley C & Tappenden P (2003) . Health Technol Assess, 7(4), iii-62.
Walters SJ, Whitfield M, Akehurst RL & Chilcott JB (2003) . Pharmacoeconomics, 21(2), 129-138.
Chilcott JB, Holmes MW, Walters S, Akehurst RL & Nashan B (2002) . Transpl Int, 15(9-10), 486-493.
Kaltenthaler E, Shackley P, Stevens K, Beverley C, Parry G & Chilcott J (2002) . Health Technology Assessment, 6(22).
Chilcott J, Tappenden P, Jones ML & Wight JP (2001) . Clin Ther, 23(11), 1792-1823.
Walters SJ, Whitfield M, Akehurst RL & Chilcott JB (2001) . Transplant Proc, 33(7-8), 3187-3191.
Chilcott JB, Whitby SM & Moore R (2001) . Transplant Proc, 33(5A Suppl), 32S-39S.
Cornell SJ, Chilcott JB & Brennan A (2001) . J Epidemiol Community Health, 55(7), 521-527.
Chilcott J, Wight J, Jones ML & Tappenden P (2001) . Health Technology Assessment, 5(19).
Chilcott JB, Holmes M, Walters S & Akehurst RL (2001) Modeling long-term results of basiliximab (SIMULECT) use in patients after kidney transplantation in Great Britain. Przegla̧d lekarski, 58(2), 61-66.
Chilcott JB, Holmes M, Walters S & Akehurst RL (2001) [Modeling long-term results of basiliximab (SIMULECT) use in patients after kidney transplantation in Great Britain].. Przegl Lek, 58(2), 61-66.
Payne N, Chilcott J & McGoogan E (2000) . Cytopathology, 11(6), 469-470.
Payne N, Chilcott J & McGoogan E (2000) . Health Technology Assessment, 4(18).
Akehurst R, Chilcott J & Holmes M (1999) The economic implications of the use of basiliximab versus placebo for the control of acute cellular rejection in renal allograft recipients.. TRANSPLANTATION, 67(7), S155-S155.
CHILCOTT JB & CHRISTER AH (1991) MODELING OF CONDITION BASED MAINTENANCE AT THE COAL FACE. INT J PROD ECON, 22(1), 1-11.
Mandrik O, Thomas C, Akpan E, Catto JWF & Chilcott J () . PharmacoEconomics.
Cooper K, Nalbant G, Sutton A, Harnan S, Thokala P, Chilcott J, McNeill A & Bessey A () . International Journal of Neonatal Screening, 10(3), 56-56.
Cooper K, Nalbant G, Sutton A, Harnan S, Thokala P, Chilcott J, McNeill A & Bessey A () . International Journal of Neonatal Screening, 10(3), 49-49.
Chang J-YA, Chilcott JB & Latimer NR () . PharmacoEconomics.
Mahdi S, Buckland NJ & Chilcott J () . Frontiers in Nutrition, 10.
Essat M, Cooper K, Bessey A, Clowes M, Chilcott JB & Hunter KD () . Head & Neck.
Mahdi S, Buckland N & Chilcott J () . Obesity Abstracts.
Jones, R , Everson-Hock ES, Guillaume, L , Clapton, J , Goyder, E , Chilcott, J , Payne, N , Duenas, A , Sheppard, LM & Swann, C () . Families, Relationships & Societies, 1(1), 71-85.
Chilcott J, Jones ML & Wilkinson A () . Health Technology Assessment, 13(Suppl 1), 7-13.
Michaels J, Wilson E, Maheswaran R, Radley S, Jones G, Tong T-S, Kaltenthaler E, Aber A, Booth A, Buckley Woods H , Chilcott J et al () . Programme Grants for Applied Research, 9(5), 1-150.

Chapters

Payne N, Akehurst R, Beard S, Brennan A, Calvert N, Chilcott J, Mccabe C, Paisley S & Ward S (2017) Supporting purchasing in acute specialties in the trent region, Controlling Costs: Strategic Issues in Health Care Management (pp. 118-130).

Conference proceedings papers

Chang JYA, Rex SS, Chilcott JB & Latimer NR (2024) ENHANCED RANDOMISED CONTROLLED TRIALS-REAL- WORLD EVIDENCE (RCT-RWE) AGREEMENT ASSESSMENT METRICS FOR HEALTH TECHNOLOGY ASSESSMENT (HTA). VALUE IN HEALTH, Vol. 27(12)
Mahdi S, Buckland N & Chilcott J (2020) STAKEHOLDER ENGAGEMENT FOR THE CONCEPTUAL MODELLING OF DIETARY DIGITAL INTERVENTIONS. MEDICAL DECISION MAKING, Vol. 40(5) (pp E458-E459)
Amy J-YC, Latimer NR, Gillespie D & Chilcott J (2020) PREVALENCE, CHARACTERISTICS AND KEY ISSUES OF MODELLING TREATMENT SEQUENCES IN HEALTH ECONOMIC EVALUATIONS: A SYSTEMATIC REVIEW OF NICE TECHNOLOGY APPRAISALS. VALUE IN HEALTH, Vol. 23 (pp S606-S606)
Xie J, Knoll S, Slowley A, Bensimon A, Vieira J, Chilcott J, Paisley S & Zhou Z (2018) . Value in Health, Vol. 21 (pp S29-S29)
Aber A, Tong T, Chilcott J, Maheswaran R, Thomas S, Nawaz S & Michaels J (2018) RISK ADJUSTMENT FOR COMORBIDITIES IN AORTIC ANEURYSM SURGERY. BRITISH JOURNAL OF SURGERY, Vol. 105 (pp 8-8)
Bessey A, Leaviss J, de la Cruz GC, Chilcott J & Wong R (2017) THE COST-EFFECTIVENESS OF SCREENING FOR SEVERE COMBINED IMMUNODEFICIENCY (SCID) IN THE UK NHS NEWBORN BLOODSPOT SCREENING PROGRAMME. VALUE IN HEALTH, Vol. 20(9) (pp A501-A501)
Paisley S, Seva J, Stevenson M, Archer R, Preston L, Chilcott J & Thornhill M (2016) . Value in Health, Vol. 19(7) (pp A367-A367)
Kearns B, Chilcott & whyte (2016) Flexible parametric survival models and time-series analysis for extrapolating time-varying treatment effects in health technology assessment. Flexible parametric survival models and time-series analysis for extrapolating time-varying treatment effects in health technology assessment, 5 September 2016 - 8 September 2016.
Thomas C, Watson P, Squires H, Chilcott J & Brennan A (2014) . Value in Health, Vol. 17(7) (pp A556-A556)
Thomas C, Watson P, Greaves C, Squires H, Chilcott J & Brennan A (2014) . Value in Health, Vol. 17(7) (pp A347-A347)
Bessey A, Chilcott J, Pandor A & Paisley S (2014) . Value in Health, Vol. 17(7) (pp A531-A531)
Brereton L, Goyder E, Ingleton C, Gardiner C, Chilcott J, van der Wilt GJ, Oortwijn W, Mozygemba K, Lysdahl KB, Sacchini D & Lepper W (2014) . BMJ Support Palliat Care, Vol. 4 Suppl 1 (pp A40-A41). England
Bessey A, Whyte S, Minton J & Chilcott J (2013) . VALUE IN HEALTH, Vol. 16(7) (pp A407-A407)
Tappenden P, Brennan A, Chilcott J & Squires H (2011) . VALUE IN HEALTH, Vol. 14(7) (pp A469-A470)
Tappenden P, Brennan A, Chilcott J & Squires H (2011) . VALUE IN HEALTH, Vol. 14(7) (pp A243-A243)
Payne N, Goyder E, Chilcott J, Sidwell A, Ram V, Buckley-Woods H, Guillaume L & Paisley S (2011) . J EPIDEMIOL COMMUN H, Vol. 65
Duenas A, Tutuncu GY & Chilcott JB (2009) . IMA JOURNAL OF MANAGEMENT MATHEMATICS, Vol. 20(4) (pp 369-383)
Mahdi S, Marr C, Buckland N & Chilcott J () . Obesity Abstracts

Reports

Chang J-YA, Chilcott JB & Latimer NR (2024) Leveraging real-world data to assess treatment sequences in health economic evaluations: a study protocol for emulating target trials using the English Cancer Registry and US Electronic Health Records-Derived Database
Whyte S, Thomas C, Kearns B, Webster M & Chilcott J (2017) Optimising Bowel Cancer Screening Phase 1: Optimising the cost effectiveness of repeated FIT screening and screening strategies combining bowel scope and FIT screening

Posters

Tappenden P, Brennan A, Chilcott J & Squires H Using Whole Disease Modelling to inform economic recommendations for the detection, diagnosis, treatment and followup of colorectal cancer.
Chilcott J, Mildred M & Hummel S Use of the Metropolis-Hastings algorithm in the calibration of a patient level simulation of prostate cancer screening.

Other

Pandor A, Eastham J, Beverley C, Chilcott J & Paisley S (2005) Clinical-effectiveness and cost-effectiveness of neonatal screening for inborn errors of metabolism using tandem mass spectrometry: A systematic review. INT J TECHNOL ASSESS, 21(1), 150-150.

Preprints

Cherodian R, Franklin M, Baxter S, Chilcott J & Gillespie D (2024) , Cold Spring Harbor Laboratory.
Hock ES, Franklin M, Baxter S, Clowes M, Chilcott J & Gillespie D (2023) .
Hock ES, Franklin M, Baxter S, Clowes M, Chilcott J & Gillespie D (2023) , Cold Spring Harbor Laboratory.
Cooper K, Essat M, Clowes M, Chilcott J, Hunter K & Bessey A (2022) Diagnostic accuracy of biopsy versus full excision for diagnosis of oral cancer: A systematic review.

Research group

PhD supervision

Paul Tappenden Role and value of modelling whole disease areas. Department of Health Personal Award Scheme Fellowship (Dec 2007-Nov 2010)
Mark Strong Methods for quantifying structural uncertainty in public health decision models. Medical Research Council Fellowship in Health Services/Public Health Research (Sep 2007 - Sep 2011)
Hazel Squires A methodological framework for developing the structure of public health economic models. NIHR Doctoral Research Fellowship (Oct 2010 - Oct 2013).

If you are interested in studying for a PhD in any of the areas listed under my research interests above, please contact scharr-pgr@sheffield.ac.uk.

Professional activities and memberships

Member of the Operational Research Society
Member of the Society for Social Medicine
Member of Health Technology Assessment international (HTAi)
Associate Editor for Journal of the Operational Research Society 2009-present
Guest member of NHS NTA Commissioning Board 2007

��«Ӱҵ

School of Medicine and Population Health

School of Medicine and Population Health

Jim Chilcott

Current projects

Featured publications

Journal articles

All publications

Journal articles

Chapters

Conference proceedings papers

Reports

Posters

Other

Preprints

PhD supervision

Links